{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T01:53:41Z","timestamp":1782006821064,"version":"3.54.5"},"reference-count":49,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JRM"],"abstract":"<jats:p>Objective: To compare the effect of rectus femoris diagnostic motor nerve blocks (DNB) with anaesthetics and rectus femoris muscle botulinum toxin (BoNT-A) injection in multiple sclerosis patients with unilateral stiff-knee gait.\nDesign: Prospective observational study\nSubjects\/Patients: Multiple sclerosis patients in stable condition.\nMethods: Patients underwent evaluation before and 1 hour after the anaesthetic block, and 1 month after the botulinum injection. Assessment included a 10-m walking test, a 6-minute walking test, a timed-up-and-go (TUG) test, and a Baseline Expanded Disability Status Scale (EDSS). Post-DNB and post-BoNT-A satisfaction was measured with the global assessment of efficacy scale.\nResults: Fourteen patients with unilateral stiff-knee gait due to multiple sclerosis underwent a DNB, among whom 13 received botulinum injections in the rectus femoris muscle after a satisfying test result. Positive post-DNB results correlated with significant functional improvements after BoNT-A. Higher EDSS and longer time from diagnosis correlated with poorer post-DNB and post-BoNT-A absolute outcomes.\nConclusion: DNB showed predictive value for BoNT-A outcomes, especially in the case of worse functional status. It effectively predicted endurance and walking speed improvement, while TUG showed greater improvement after botulinum. In cases of uncertain therapeutic benefit, nerve blocks may provide a valuable diagnostic support, particularly in patients with lower functional status.<\/jats:p>","DOI":"10.2340\/jrm.v56.40437","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T12:27:22Z","timestamp":1722860842000},"page":"jrm40437","source":"Crossref","is-referenced-by-count":3,"title":["Multiple sclerosis and spasticity: the role of anaesthetic nerve blocks on rectus femoris muscle. When should stiff knee be treated with botulinum toxin?"],"prefix":"10.2340","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8440-6283","authenticated-orcid":false,"given":"Alessio","family":"Baricich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1357-1374","authenticated-orcid":false,"given":"Marco","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0831-4843","authenticated-orcid":false,"given":"Margherita B.","family":"Borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8116-4802","authenticated-orcid":false,"given":"Alberto","family":"Loro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Morlino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Cosenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Bertoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3558-8276","authenticated-orcid":false,"given":"Alessandro","family":"Picelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1452-8485","authenticated-orcid":false,"given":"Andrea","family":"Santamato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6817-163X","authenticated-orcid":false,"given":"Thierry","family":"Deltombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2024,8,5]]},"reference":[{"key":"70139","doi-asserted-by":"crossref","unstructured":"Compston A, Coles A. Multiple sclerosis. Lancet 2008; 372: 1502\u20131517.","DOI":"10.1016\/S0140-6736(08)61620-7"},{"key":"70140","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S0140-6736(08)61620-7","DOI":"10.1016\/S0140-6736(08)61620-7"},{"key":"70141","doi-asserted-by":"crossref","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, et al. Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, 3rd ed. Mult Scler 2020; 26: 1816\u20131821.","DOI":"10.1177\/1352458520970841"},{"key":"70142","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1177\/1352458520970841","DOI":"10.1177\/1352458520970841"},{"key":"70143","doi-asserted-by":"crossref","unstructured":"Baricich A, Battaglia M, Cuneo D, Cosenza L, Millevolte M, Cosma M, et al. Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis: an observational longitudinal study. Front Neurol 2023; 14: 1133390.","DOI":"10.3389\/fneur.2023.1133390"},{"key":"70144","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3389\/fneur.2023.1133390","DOI":"10.3389\/fneur.2023.1133390"},{"key":"70145","doi-asserted-by":"crossref","unstructured":"Hughes C, Howard IM. Spasticity management in multiple sclerosis. Phys Med Rehabil Clin N Am 2013; 24: 593\u2013604.","DOI":"10.1016\/j.pmr.2013.07.003"},{"key":"70146","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.pmr.2013.07.003","DOI":"10.1016\/j.pmr.2013.07.003"},{"key":"70147","doi-asserted-by":"crossref","unstructured":"Baricich A, Wein T, Cinone N, Bertoni M, Picelli A, Chisari C, et al. BoNT-A for post-stroke spasticity: guidance on unmet clinical needs from a Delphi Panel approach. Toxins 2021; 13: 236.","DOI":"10.3390\/toxins13040236"},{"key":"70148","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3390\/toxins13040236","DOI":"10.3390\/toxins13040236"},{"key":"70149","doi-asserted-by":"crossref","unstructured":"Wissel J, Ward AB, Erztgaard P, Bensmail D, Hecht MJ, Lejeune TM, et al. European consensus table on the use of botulinum toxin type A in adult spas-ticity. J Rehabil Med 2009; 41: 13\u201325.","DOI":"10.2340\/16501977-0303"},{"key":"70150","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2340\/16501977-0303","DOI":"10.2340\/16501977-0303"},{"key":"70151","doi-asserted-by":"crossref","unstructured":"Elovic EP, Esquenazi A, Alter KE, Lin JL, Alfaro A, Kaelin DL. Chemodenervation and nerve blocks in the diagnosis and management of spasticity and muscle overactivity. PM R 2009; 1: 842\u2013851.","DOI":"10.1016\/j.pmrj.2009.08.001"},{"key":"70152","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.pmrj.2009.08.001","DOI":"10.1016\/j.pmrj.2009.08.001"},{"key":"70153","doi-asserted-by":"crossref","unstructured":"Picelli A, Vallies G, Chemello E, Castellazzi P, Brugnera A, Gandolfi M, et al. Is spasticity always the same? An observational study comparing the fea-tures of spastic equinus foot in patients with chronic stroke and multiple sclerosis. J Neurol Sci 2017; 380: 132\u2013136.","DOI":"10.1016\/j.jns.2017.07.026"},{"key":"70154","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jns.2017.07.026","DOI":"10.1016\/j.jns.2017.07.026"},{"key":"70155","doi-asserted-by":"crossref","unstructured":"Wagner JM, Kremer TR, Van Dillen LR, Naismith RT. Plantarflexor weakness negatively impacts walking in persons with multiple sclerosis more than plantar flexor spasticity. Arch Phys Med Rehabil 2014; 95: 1358\u20131365.","DOI":"10.1016\/j.apmr.2014.01.030"},{"key":"70156","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.apmr.2014.01.030","DOI":"10.1016\/j.apmr.2014.01.030"},{"key":"70157","doi-asserted-by":"crossref","unstructured":"Van Der Walt A, Sung S, Spelman T, Marriott M, Kolbe S, Mitchell P, et al. A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor. Neurology 2012; 79: 92\u201399.","DOI":"10.1212\/WNL.0b013e31825dcdd9"},{"key":"70158","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1212\/WNL.0b013e31825dcdd9","DOI":"10.1212\/WNL.0b013e31825dcdd9"},{"key":"70159","doi-asserted-by":"crossref","unstructured":"Moccia M, Frau J, Carotenuto A, Butera C, Coghe G, Barbero P, et al. Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study. Neurol Sci 2020; 41: 2781\u20132792.","DOI":"10.1007\/s10072-020-04392-8"},{"key":"70160","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s10072-020-04392-8","DOI":"10.1007\/s10072-020-04392-8"},{"key":"70161","unstructured":"Yurgil JL, Hulsopple CD, Leggit JC. Nerve blocks: Part I. Upper extremity. Am Fam Physician 2020; 101: 654\u2013664."},{"key":"70162","unstructured":"Yurgil JL, Hulsopple CD, Leggit JC. Nerve blocks: Part II. Lower extremity. Am Fam Physician 2020; 101: 669\u2013679."},{"key":"70163","doi-asserted-by":"crossref","unstructured":"Facciorusso S, Spina S, Gasperini G, Picelli A, Filippetti M, Molteni F, et al. Anatomical landmarks for ultrasound-guided rectus femoris diagnostic nerve block in post-stroke spasticity. Australas J Ultrasound Med 2023; 26: 236\u2013242.","DOI":"10.1002\/ajum.12354"},{"key":"70164","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/ajum.12354","DOI":"10.1002\/ajum.12354"},{"key":"70165","doi-asserted-by":"crossref","unstructured":"Robertson JV, Pradon D, Bensmail D, Fermanian C, Bussel B, Roche N. Relevance of botulinum toxin injection and nerve block of rectus femoris to kine-matic and functional parameters of stiff knee gait in hemiplegic adults. Gait Posture 2009; 29: 108\u2013112.","DOI":"10.1016\/j.gaitpost.2008.07.005"},{"key":"70166","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.gaitpost.2008.07.005","DOI":"10.1016\/j.gaitpost.2008.07.005"},{"key":"70167","unstructured":"Lance JW. Symposium synopsis. In: Feldman RG, Young RR, Koella WP, editors. Spasticity: disordered motor control. Symposia Specialists Medical Books. Distributed by Year Book Medical Publishers, Miami, FL; 1980. p. 485\u2013494."},{"key":"70168","doi-asserted-by":"crossref","unstructured":"Marinelli L, Curr\u00e0 A, Trompetto C, Capello E, Serrati C, Fattapposta F, et al. Spasticity and spastic dystonia: the two faces of velocity-dependent hyper-tonia. J Electromyogr Kinesiol Off J Int Soc Electrophysiol Kinesiol 2017; 37: 84\u201389.","DOI":"10.1016\/j.jelekin.2017.09.005"},{"key":"70169","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jelekin.2017.09.005","DOI":"10.1016\/j.jelekin.2017.09.005"},{"key":"70170","doi-asserted-by":"crossref","unstructured":"Pearson M, Dieberg G, Smart N. Exercise as a therapy for improvement of walking ability in adults with multiple sclerosis: a meta-analysis. Arch Phys Med Rehabil 2015; 96: 1339\u20131348.e7.","DOI":"10.1016\/j.apmr.2015.02.011"},{"key":"70171","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.apmr.2015.02.011","DOI":"10.1016\/j.apmr.2015.02.011"},{"key":"70172","doi-asserted-by":"crossref","unstructured":"Baricich A, Grana E, Carda S, Santamato A, Cisari C, Invernizzi M. High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis. J Neural Transm Vienna Austria 1996 2015; 122: 1283\u20131287.","DOI":"10.1007\/s00702-015-1384-6"},{"key":"70173","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s00702-015-1384-6","DOI":"10.1007\/s00702-015-1384-6"},{"key":"70174","doi-asserted-by":"crossref","unstructured":"Tang A, Eng JJ, Rand D. Relationship between perceived and measured changes in walking after stroke. J Neurol Phys Ther 2012; 36: 115\u2013121.","DOI":"10.1097\/NPT.0b013e318262dbd0"},{"key":"70175","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/NPT.0b013e318262dbd0","DOI":"10.1097\/NPT.0b013e318262dbd0"},{"key":"70176","doi-asserted-by":"crossref","unstructured":"Tilson JK, Sullivan KJ, Cen SY, Rose DK, Koradia CH, Azen SP, et al. Meaningful gait speed improvement during the first 60 days poststroke: minimal clinically important difference. Phys Ther 2010; 90: 196\u2013208.","DOI":"10.2522\/ptj.20090079"},{"key":"70177","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2522\/ptj.20090079","DOI":"10.2522\/ptj.20090079"},{"key":"70178","doi-asserted-by":"crossref","unstructured":"Perry J, Garrett M, Gronley JK, Mulroy SJ. Classification of walking handicap in the stroke population. Stroke 1995; 26: 982\u2013989.","DOI":"10.1161\/01.STR.26.6.982"},{"key":"70179","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1161\/01.str.26.6.982","DOI":"10.1161\/01.STR.26.6.982"},{"key":"70180","doi-asserted-by":"crossref","unstructured":"Gautschi OP, Stienen MN, Corniola MV, Joswig H, Schaller K, Hildebrandt G, et al. Assessment of the minimum clinically important difference in the timed up and go test after surgery for lumbar degenerative disc disease. Neurosurgery 2017; 80: 380\u2013385.","DOI":"10.1227\/NEU.0000000000001320"},{"key":"70181","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1227\/NEU.0000000000001320","DOI":"10.1227\/NEU.0000000000001320"},{"key":"70182","doi-asserted-by":"crossref","unstructured":"Maldaner N, Sosnova M, Ziga M, Zeitlberger AM, Bozinov O, Gautschi OP, et al. External validation of the minimum clinically important difference in the timed-up-and-go test after surgery for lumbar degenerative disc disease. Spine 2022; 47: 337\u2013342.","DOI":"10.1097\/BRS.0000000000004128"},{"key":"70183","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/BRS.0000000000004128","DOI":"10.1097\/BRS.0000000000004128"},{"key":"70184","doi-asserted-by":"crossref","unstructured":"Giovannelli M, Borriello G, Castri P, Prosperini L, Pozzilli C. Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spas-ticity in patients with multiple sclerosis. Clin Rehabil 2007; 21: 331\u2013337.","DOI":"10.1177\/0269215507072772"},{"key":"70185","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1177\/0269215507072772","DOI":"10.1177\/0269215507072772"},{"key":"70186","doi-asserted-by":"crossref","unstructured":"Li S. Spasticity, motor recovery, and neural plasticity after stroke. Front Neurol 2017; 8: 120.","DOI":"10.3389\/fneur.2017.00120"},{"key":"70187","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3389\/fneur.2017.00120","DOI":"10.3389\/fneur.2017.00120"}],"container-title":["Journal of Rehabilitation Medicine"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/jrm\/article\/download\/40437\/46834","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/jrm\/article\/download\/40437\/46834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T12:27:47Z","timestamp":1722860867000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/jrm\/article\/view\/40437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,5]]},"references-count":49,"URL":"https:\/\/doi.org\/10.2340\/jrm.v56.40437","relation":{},"ISSN":["1651-2081"],"issn-type":[{"value":"1651-2081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,5]]}}}